2.13USD
355.76 MUSD
1.66 BUSD
166.70 M
About Alkermes plc
Sector
CEO
Richard F. Pops
Headquarters
Dublin
Website
Employees (FY)
2.1 K
Founded
2011
ISIN
IE00B56GVS15
FIGI
BBG000C9F2F9
Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ALKS is 24.65 USD — it has increased by 1.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alkermes plc stocks are traded under the ticker ALKS.
Alkermes plc is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
ALKS stock is 2.69% volatile and has beta coefficient of 0.55. Check out the list of the most volatile stocks — is Alkermes plc there?
ALKS earnings for the last quarter are 0.59 USD per share, whereas the estimation was 0.40 USD resulting in a 50.23% surprise. The estimated earnings for the next quarter are 0.45 USD per share. See more details about Alkermes plc earnings.
Alkermes plc revenue for the last quarter amounts to 380.94 M USD despite the estimated figure of 362.31 M USD. In the next quarter revenue is expected to reach 362.22 M USD.
Yes, you can track Alkermes plc financials in yearly and quarterly reports right on TradingView.
ALKS stock has risen by 2.97% compared to the previous week, the month change is a 9.94% fall, over the last year Alkermes plc has showed a 15.84% decrease.
ALKS net income for the last quarter is 112.78 M USD, while the quarter before that showed 47.76 M USD of net income which accounts for 136.15% change. Track more Alkermes plc financial stats to get the full picture.
Today Alkermes plc has the market capitalization of 4.10 B, it has increased by 1.26% over the last week.
No, ALKS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALKS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alkermes plc stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 2.10 K employees. See our rating of the largest employees — is Alkermes plc on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Alkermes plc technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Alkermes plc stock shows the strong sell signal. See more of Alkermes plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Alkermes plc future price: according to them, ALKS price has a max estimate of 50.00 USD and a min estimate of 23.00 USD. Read a more detailed Alkermes plc forecast: see what analysts think of Alkermes plc and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alkermes plc EBITDA is 364.79 M USD, and current EBITDA margin is 29.40%. See more stats in Alkermes plc financial statements.